Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation

Clinical trial NCT07561554 · RECRUITING

Trial details

NCT number: NCT07561554
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors (Phase 1)

Start date: 2026-03-06
Primary completion: 2028-12-02
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.